Рецепторы, активируемые пероксисомным пролифератором (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Рецепторы, активируемые пероксисомным пролифератором" in Russian language version.

refsWebsite
Global rank Russian rank
4th place
6th place
2nd place
3rd place
11th place
286th place
18th place
63rd place
5th place
5th place
low place
low place

doi.org

  • Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W (2006). "International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors". Pharmacol. Rev. 58 (4): 726—41. doi:10.1124/pr.58.4.5. PMID 17132851. S2CID 2240461.
  • Dunning, Kylie R.; Anastasi, Marie R.; Zhang, Voueleng J.; Russell, Darryl L.; Robker, Rebecca L. (2014-02-05). "Regulation of Fatty Acid Oxidation in Mouse Cumulus-Oocyte Complexes during Maturation and Modulation by PPAR Agonists". PLOS ONE. 9 (2): e87327. Bibcode:2014PLoSO...987327D. doi:10.1371/journal.pone.0087327. ISSN 1932-6203. PMC 3914821. PMID 24505284.
  • Belfiore A, Genua M, Malaguarnera R (2009). "PPAR-gamma Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer". PPAR Res. 2009: 830501. doi:10.1155/2009/830501. PMC 2709717. PMID 19609453.
  • Berger J, Moller DE (2002). "The mechanisms of action of PPARs". Annu. Rev. Med. 53: 409—35. doi:10.1146/annurev.med.53.082901.104018. PMID 11818483.
  • Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W (2006). "From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions". Prog. Lipid Res. 45 (2): 120—59. doi:10.1016/j.plipres.2005.12.002. PMID 16476485.
  • Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S (October 2011). "The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases". J Adv Pharm Technol Res. 2 (4): 236—40. doi:10.4103/2231-4040.90879. PMC 3255347. PMID 22247890.
  • Zoete V, Grosdidier A, Michielin O (2007). "Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators". Biochim. Biophys. Acta. 1771 (8): 915—25. doi:10.1016/j.bbalip.2007.01.007. PMID 17317294.
  • Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W (1992). "Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors". Cell. 68 (5): 879—87. doi:10.1016/0092-8674(92)90031-7. PMID 1312391. S2CID 3148132.

harvard.edu

ui.adsabs.harvard.edu

medspecial.ru

  • Фибраты // Доказательная медицина для всех. — Дата обращения: 09.12.2019.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W (2006). "International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors". Pharmacol. Rev. 58 (4): 726—41. doi:10.1124/pr.58.4.5. PMID 17132851. S2CID 2240461.
  • Dunning, Kylie R.; Anastasi, Marie R.; Zhang, Voueleng J.; Russell, Darryl L.; Robker, Rebecca L. (2014-02-05). "Regulation of Fatty Acid Oxidation in Mouse Cumulus-Oocyte Complexes during Maturation and Modulation by PPAR Agonists". PLOS ONE. 9 (2): e87327. Bibcode:2014PLoSO...987327D. doi:10.1371/journal.pone.0087327. ISSN 1932-6203. PMC 3914821. PMID 24505284.
  • Belfiore A, Genua M, Malaguarnera R (2009). "PPAR-gamma Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer". PPAR Res. 2009: 830501. doi:10.1155/2009/830501. PMC 2709717. PMID 19609453.
  • Berger J, Moller DE (2002). "The mechanisms of action of PPARs". Annu. Rev. Med. 53: 409—35. doi:10.1146/annurev.med.53.082901.104018. PMID 11818483.
  • Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W (2006). "From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions". Prog. Lipid Res. 45 (2): 120—59. doi:10.1016/j.plipres.2005.12.002. PMID 16476485.
  • Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S (October 2011). "The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases". J Adv Pharm Technol Res. 2 (4): 236—40. doi:10.4103/2231-4040.90879. PMC 3255347. PMID 22247890.
  • Zoete V, Grosdidier A, Michielin O (2007). "Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators". Biochim. Biophys. Acta. 1771 (8): 915—25. doi:10.1016/j.bbalip.2007.01.007. PMID 17317294.
  • Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W (1992). "Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors". Cell. 68 (5): 879—87. doi:10.1016/0092-8674(92)90031-7. PMID 1312391. S2CID 3148132.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

  • Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W (2006). "International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors". Pharmacol. Rev. 58 (4): 726—41. doi:10.1124/pr.58.4.5. PMID 17132851. S2CID 2240461.
  • Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W (1992). "Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors". Cell. 68 (5): 879—87. doi:10.1016/0092-8674(92)90031-7. PMID 1312391. S2CID 3148132.

worldcat.org